Overview of Genetic Test Development for Inflammatory Diseases

Biomarkers, Laboratory Technology, Life Sciences,
  • Tuesday, June 11, 2019

Healthcare expenditures in the United States are growing at an alarming level with the Centers for Medicare and Medicaid Services (CMS) projecting that they will reach $5.7 trillion per year by 2026. Inflammatory diseases and related syndromes are growing in prevalence among Western societies. These diseases affect close to 60 million people in the US and place a significant burden on the healthcare system. Characterized by relatively slow development, these diseases and syndromes prove challenging to diagnose, leading to delayed treatment against the backdrop of inevitable disability progression.

Patients require healthcare attention but are initially hidden from a clinician’s view by the seemingly generalized, non-specific symptoms. It is imperative to identify and manage these underlying conditions to slow disease progression and reduce the likelihood that costly comorbidities will develop. Enhanced diagnostic criteria coupled with additional technological innovation to identify inflammatory conditions earlier is necessary and in the best interest of all healthcare stakeholders.

In this free webinar, the featured speaker will discuss: 

  • RNA Molecular Diagnostics
  • Sample collection and stabilization
  • Genomic Test Development
  • Case study: PAXgene Blood RNA Tube in genomic tests


Chase Spurlock, IQuity

Chase Spurlock, PhD, Chief Executive Officer, IQuity

Dr. Chase Spurlock, is Founder and CEO of IQuity, a Nashville-based data analytics company that works with stakeholders to lower the cost of healthcare and improve outcomes by finding and fixing addressable autoimmune disease risk. Dr. Spurlock is a Phi Beta Kappa graduate of The University of the South and received his PhD in immunology from Vanderbilt, where he also serves on the faculty. His work in genomics and data science has been featured in peer-reviewed journals and widely published in trade journals and healthcare media outlets. He is also an industry innovator listed on the Nashville Business Journal ’40 under 40’ list and Nashville Medical News InCharge.

Message Presenter

Who Should Attend?

This webinar will appeal to individuals working in biotech or life sciences research with the following or related job titles:

  • Molecular Lab Managers
  • Diagnostic Assay Development Staff
  • Pharma Researchers
  • Academic Researchers
  • Clinical Research Organizations
  • Clinical Project Managers
  • Biorepository and Biobank Managers

What You Will Learn

Attendees will learn about: 

  • RNA Molecular Diagnostics
  • Sample collection and stabilization
  • Genomic Test Development
  • Case study: PAXgene Blood RNA Tube in genomic tests

Xtalks Partner


IQuity is a Nashville-based analytics company offering the only autoimmune disease-focused data analytics platform for self-insured employers and health plans who are pressured to find new ways to lower the cost of healthcare. IQuity’s platform predicts, detects and monitors autoimmune disease and improves outcomes by targeting patients earlier leading to lower disability and costs.

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account